Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Timothy M. Crowder"'
Autor:
William M. Abraham, Dale J. Christensen, Juan R. Sabater, David W. Scott, Matthew P. Walker, Bryant Wu, Timothy J. Stuhlmiller, Juliana I. Sesma, Robert Tarran, Timothy M. Crowder
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 196:734-744
Rationale: Cystic fibrosis (CF) lung disease is caused by the loss of function of the cystic fibrosis transmembrane conductance regulator (CFTR) combined with hyperactivation of the epithelial sodium channel (ENaC). In the lung, ENaC is responsible f
Autor:
Phillip Barley, Timothy M. Crowder, Dale J. Christensen, Matt Cowlen, Matthew P. Walker, Mutsumi Miyamoto
Publikováno v:
Inhalation Toxicology. 29:356-365
ENaC inhibition has long been an attractive therapeutic target for the treatment of cystic fibrosis. However, previous attempts at developing ENaC inhibitors have been unsuccessful due to complications arising from systemic circulation of the compoun
Autor:
Timothy M. Crowder, Christie Hudson, Paulina Farias, Peter Couroux, Robert Tarran, K. Griffin, Leena Rizvi, Elizabeth Tullis
Publikováno v:
Pulmonary pharmacologytherapeutics. 58
Background ENaC inhibition has been investigated as a CF treatment; however, small molecule inhibitors of ENaC lack efficacy and/or have shown dose-limiting hyperkalemia . SPX-101 is a novel, investigational small peptide (SPLUNC1 mimetic) that regul
Autor:
Timothy M. Crowder
Publikováno v:
Powder Technology. 173:217-223
A proof of concept prototype has been constructed to test the capabilities of using vibration frequencies determined from rotating drum powder flow characterization to reproducibly fill small unit doses of pharmaceutical powders. A lactose excipient
Autor:
Matthew S. Ferriter, Juan Huang, C. Robin Hwang, Robert J. Garmise, Vincent J. Sullivan, Anthony J. Hickey, John A. Mikszta, Kevin D. Mar, Timothy M. Crowder
Publikováno v:
AAPS PharmSciTech. 7:E131-E137
The purpose of this research was to prepare a dry powder vaccine formulation containing whole inactivated influenza virus (VIIV) and a mucoadhesive compound suitable for nasal delivery. Powders containing WIIV and either lactose or trehalose were pro
Autor:
Vincent J. Sullivan, C. Robin Hwang, Anthony J. Hickey, Juan Huang, Robert J. Garmise, John A. Mikszta, Kevin D. Mar, Timothy M. Crowder
Publikováno v:
Vaccine. 23:794-801
Intranasal (i.n.) vaccination represents an attractive non-invasive alternative to needle-based injection and provides superior protection at mucosal surfaces. However, new formulations are needed to improve efficacy and reduce the refrigerated stora
Publikováno v:
Pharmaceutical Research. 19:239-245
Key factors that contribute to the aerodynamic properties of aerosol particles are found in Stokes' law. These factors may be monitored or controlled to optimize drug delivery to the lungs. Predictions of the aerodynamic behavior of therapeutic aeros
Publikováno v:
Journal of Cystic Fibrosis. 16:S37
Publikováno v:
Particle & Particle Systems Characterization. 16:191-196
Previous studies of the flow of granular materials in a rotating drum have described the observed time sequences of angle of repose or time to avalanche. The time between avalanches approach has been incorporated into a commercially available powder
Autor:
R. Fellner, J. Neill, J. Hairr, D.J. Christensen, Robert Tarran, S. Terryah, Timothy M. Crowder
Publikováno v:
Journal of Cystic Fibrosis. 15:S4